Scott Eggener@uroegg

Truth and science matter. Support both. Professor and Chair of Urology - UCLA

 Los Angeles
uclahealth.org/departments/u…
Joined February 2013
275 Photos and videos
Essential for all physicians and surgeons to be aware of new policy from Jehovah's Witnesses jw.org/finder?wtlocale=E&doc…

Jehovah’s Witnesses: Each Witness Now Decides Whether to Accept or Donate Main Blood Components

jw.org
2
6
32
5,006
Scott Eggener retweeted
Dave Penson@urogeek
Sep 19
Replying to @uroegg @dr_coops
Scott, you know where I stand on this. Molecular features don’t matter when clinical characteristics are BENIGN. Let’s be pragmatic. Patients don’t understand. I think this would be a great topic for the plenary at the AUA annual meeting. 😉 @AmerUrological
2
2
8
2,880
"GG1 shares molecular features with higher grade cancer, we must call it cancer" "Great point, let's look into it" Every one also present in benign and pre cancers, fairly certain we shouldn't call those cancers QED to that counterargument bjui-journals.onlinelibrary.…

Is Gleason pattern 3 cancer? Molecular features do not distinguish pattern 3 from benign tissue

Click on the article title to read more.

bjui-journals.onlinelibrary.wiley.com
2
9
51
10,967
Set your precons aside, read this, and buckle up!! jamanetwork.com/journals/jam…

Will Autonomous AI Exceed AI-Aided Physicians as the Best Medical Care?

This Perspective discusses the advantages and disadvantages of physician-led medical care vs that provided by artificial intelligence (AI).

jamanetwork.com
5
2
18
7,344
How cool is this? Closer to the holy grail of immunosuppression-free solid organ transplant, spearheaded by one of our urologists: Jeff Veale A first of its kind organ transplant technique tried on a human subject nbcnews.com/video/a-first-of… via @nbcnews @UclaUrology

A first of its kind organ transplant technique tried on a human subject

Meet the first-ever liver transplant patient to receive stem cells from their donor, in the hope of avoiding toxic anti-rejection drugs. NBC News' Camila Bernal spoke to the patient who received a...

nbcnews.com
3
4
45
7,703
No surprise, Dr Scotland is a superstar. uclahealth.org/news/release/… @DrKScotland @UclaUrology

Dr. Kymora B. Scotland honored with the Endourological Society Arthur Award

UCLA Health’s Dr. Kymora B. Scotland has been recognized by the Endourological Society’s 2026 Arthur Smith Award, an honor granted to urologists who are within 10 years of completing their residency...

uclahealth.org
7
2
52
5,883
Release the hounds......try to stay civil folks @TylerSbrt @AbhinavSidana @EmbertonMark @daviesbj statnews.com/2026/08/21/foca…

Focal therapy for localized prostate cancer has divided physicians. Will new data change minds?

Urologic oncologists who treat prostate cancer are split over the benefits of focal therapy compared to traditional surgery or radiation.

statnews.com
9
6
29
19,559
Yet again, the VA aspirationally showing us how prostate cancer should be managed! jamanetwork.com/journals/jam… @dr_coops

Active Surveillance Use for Favorable-Risk Prostate Cancer in a Veteran Population

This Research Letter describes the incidence and quality of active surveillance use for prostate cancer in the national Veterans Affairs Healthcare System.

jamanetwork.com
7
48
11,576
Great study. Need more of these My kinda sorta version of this: "try tamsulosin for a few weeks; if it isn't helping, stop it" Tamsulosin Deprescribing for Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men jamanetwork.com/journals/jam…

Tamsulosin Deprescribing for Lower Urinary Tract Symptoms in Older Men

This crossover trial evaluates whether N-of-1 deprescribing trials can identify older men who are receiving minimal benefit from tamsulosin therapy for lower urinary tract symptoms.

jamanetwork.com
4
19
58
13,195
Yet another reminder that thoughtful PrCa screening, risk-based management, and equal access can have tremendous value for individual and population health The more we minimize overDx and overRx, the more men will be screened and have their lives saved jamanetwork.com/journals/jam…

Cancer Type–Specific Contributions to Cancer Mortality Gap by Race

This cross-sectional temporal analysis examines cancer type–specific contributions to the reduction in all-cancer excess mortality rate among Black population compared with White population between...

jamanetwork.com
1
7
22
3,634
This will definitely stimulate some debate....and should Surgeon Sleep Patterns and Patient Risk of Major Adverse Events jamanetwork.com/journals/jam…

Surgeon Social Jet Lag and Patient Risk of Major Adverse Events

This cohort study investigates the association between surgeon sleep timing regularity and patient outcomes.

jamanetwork.com
6
9
56
50,905
First ever locally injectable immunoactive agent with proven DFS benefit in localized prostate cancer. Tandem randomized Phase II in surveillance forthcoming. Origin: Baylor basic science lab (support research!) thelancet.com/journals/lanon…

Aglatimagene besadenovec (CAN-2409) with radiotherapy for patients with localised prostate cancer:...

Aglatimagene plus valacyclovir was associated with longer disease-free survival than placebo plus valacyclovir when added to standard of radiotherapy for the treatment of localised prostate cancer,...

thelancet.com
1
15
47
5,883
The Influence of Urology on Longevity JAMA article from 1926: vaccines, clean water, and Urology (?!?!) responsible for dramatic lengthening of life expectancy jamanetwork.com/journals/jam…

The Influence of Urology on Longevity

B. A. Thomas, M.D., Philadelphia

jamanetwork.com
2
8
57
6,707
It's entirely plausible that renaming Grade Group 1 (Gleason 6) PrCa can save a whole lot of lives. Consider reading and discussing. Editorial by @OtisBrawley @dr_coops @VickersBiostats @GladellPaner @UCLAHealth @UCLAHealthJCCC jamanetwork.com/journals/jam…

Prostate Cancer Mortality After Relabeling Low-Grade Prostate Cancer as Precancerous

This decision analytical model study evaluates the effects of relabeling grade group 1 prostate cancer on prostate cancer mortality in the US.

jamanetwork.com
7
27
101
12,783
Makes me sad. RCT's are essential to help individuals and improve public health. Clinician-scientists (and others) have work to do to fix this divide. Clinical Trial Skepticism and Political Ideology Among US Adults and Cancer Survivors jamanetwork.com/journals/jam…

Clinical Trial Skepticism and Political Ideology Among US Adults and Cancer Survivors

This cross-sectional study examines the association of political ideology and clinical trial skepticism in a nationally representative US sample and in a subpopulation of cancer survivors.

jamanetwork.com
2
7
33
4,698
Exhibit A: jamanetwork.com/journals/jam…

Retracted Randomized Clinical Trials From Authors With Multiple Retractions

This cohort study evaluates the author and publication characteristics of retracted randomized clinical trials.

jamanetwork.com
1
6
1,042
Release the hounds...... Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival in Early Ovarian Cancer jamanetwork.com/journals/jam…

Minimally Invasive Surgery, Intraoperative Capsule Rupture, and Survival in Early Ovarian Cancer

This cohort study examines the associations of minimally invasive surgery, intraoperative capsule rupture, and overall survival among patients with stage I ovarian cancer.

jamanetwork.com
1
15
3,257
Cheap, easy, and reliable for ADT-induced hot flashes: oxybutynin for the win!! Dries up perspiration and the mouth. ascopubs.org/doi/10.1200/JCO…

Old Dog, New Tricks: Oxybutynin for the Treatment of Androgen Deprivation Therapy–Related Vasomotor...

ascopubs.org
5
21
95
10,032
For those of us who still do some laparotomies. Small vs Large Bites for Abdominal Midline Incisions jamanetwork.com/journals/jam…
6
23
100
12,424
Whoa.....what's old is new again! Transdermal Estradiol Patches in Locally Advanced Prostate Cancer | New England Journal of Medicine nejm.org/doi/full/10.1056/NE…

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer | NEJM

Transdermal estradiol (tE2) is an alternative to luteinizing hormone–releasing hormone (LHRH) agonists as androgen-deprivation therapy in patients with prostate cancer. With tE2, testosterone is su...

nejm.org
2
18
64
8,877
Load more